Hinge Health Inc.
Organization details
- Legal name
- Hinge Health Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Information Technology
- SIC code
- 7374 — Services-Computer Processing & Data Preparation
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HNGE
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001673743
- EIN
- 81-1884841
Board of directors
-
Daniel Antonio Perez · Director · CEO & Co-FounderSince 2025
-
Elliott Robinson · DirectorSince 2025
-
Gabriel M.i. Mecklenburg · DirectorSince 2025
-
Kristina M. Leslie · DirectorSince 2025
-
Teddie Benjamin Wardi · DirectorSince 2025
-
Tyler Sloat · DirectorSince 2026
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
50.6% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.9%
-
99.8%
Board connections
2 of this board's directors also sit on 2 other boards. 1 is in the same sector.
-
SentinelOne Inc. Same sectorvia Teddie Benjamin Wardi
- via Kristina M. Leslie
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $543,078,858
- 218 sales by 11 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 5, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 5, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 4, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 4, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 4, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 4, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 4, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 4, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 4, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 4, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 4, 2026 | Elliott Robinson Director | Open-market sale | −0 | — | — |
| Nov 1, 2026 | Budge James Officer (Chief Financial Officer) | Shares withheld for tax | −4,614 | $114.32 | $527,472 |
| Nov 1, 2026 | Pursley James Officer (President) | Shares withheld for tax | −831 | $114.32 | $95,000 |
| Oct 12, 2026 | Budge James Officer (Chief Financial Officer) | Open-market sale | −2,100 | $101.53 | $213,207 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Hinge Health Inc.
Who is the CEO of Hinge Health Inc.?
Daniel Antonio Perez has been Hinge Health Inc.'s CEO & Co-Founder since May 2025.
How many directors are on Hinge Health Inc.'s board?
Hinge Health Inc.'s board has 6 directors: Daniel Antonio Perez, Elliott Robinson, Gabriel M.i. Mecklenburg, Kristina M. Leslie, Teddie Benjamin Wardi and Tyler Sloat.
Are Hinge Health Inc. insiders buying or selling shares?
Over the last 12 months, Hinge Health Inc. insiders made no open-market purchases and sold $543.1 million of shares in 218 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="hinge-health-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.